FDA Approved: LUNSUMIO — Original Application (Genentech, Inc.)

View source ↗

Summary

The FDA approved Lunsumio (mosunetuzumab) from Genentech in an original application for adults with relapsed or refractory follicular lymphoma after at least tw…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma

Drugs mentioned

• LUNSUMIO (mosunetuzumab)

Snippet

ORIG AP for LUNSUMIO (MOSUNETUZUMAB)